Want to see IN:VIVIMEDLAB full AI Analyst Report?
Vivimed Labs Limited (VIVIMEDLAB) Financial Statements
Vivimed Labs Limited Financial Overview
Vivimed Labs Limited's market cap is currently $506.60M. The company's EPS TTM is $-21.28; its P/E ratio is -0.26; and it has a dividend yield of 0.67%. Vivimed Labs Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 699.89M | $ 1.16B | $ 1.49B | $ 1.87B | $ 2.37B |
| Gross Profit | $ -547.76M | $ 77.98M | $ 705.71M | $ -928.65M | $ 838.04M |
| Operating Income | $ -1.78B | $ -332.72M | $ -148.14M | $ -1.22B | $ -250.73M |
| EBITDA | $ -1.46B | $ -86.77M | $ -246.69M | $ -1.86B | $ -67.91M |
| Net Income | $ -1.76B | $ -319.61M | $ -454.46M | $ -3.29B | $ -676.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.56M | $ 7.08M | $ 717.79M | $ 37.62M | $ 71.84M |
| Total Assets | $ 7.53B | $ 9.21B | $ 9.51B | $ 9.88B | $ 12.66B |
| Total Debt | $ 3.97B | $ 3.76B | $ 3.79B | $ 3.81B | $ 2.78B |
| Net Debt | $ 3.96B | $ 3.76B | $ 3.77B | $ 3.77B | $ 2.71B |
| Total Liabilities | $ 9.64B | $ 9.56B | $ 9.56B | $ 9.49B | $ 9.02B |
| Stockholders' Equity | $ -2.11B | $ -351.69M | $ -54.61M | $ 394.23M | $ 3.64B |
| Cash Flow | |||||
| Free Cash Flow | $ 67.56M | $ -86.28M | $ -260.30M | $ 303.54M | $ -6.75B |
| Operating Cash Flow | $ 77.03M | $ -40.97M | $ -239.91M | $ 138.12M | $ -6.58B |
| Investing Cash Flow | $ -9.47M | $ -45.31M | $ 282.88M | $ -49.68M | $ 5.23B |
| Financing Cash Flow | $ -61.07M | $ 73.10M | $ -60.32M | $ -162.44M | $ -103.80M |
Currency in INR